Evidence map›Paper›PMID 42446933›Full record

ArticleJCI insight2026

A whole-blood cryopreservation method streamlines clinical sample collection for multimodal single-cell immune profiling in sepsis.

Alyssa K DuBois, Pierre O Ankomah, Alexis C Campbell, Renee Hua, Olivia K Nelson, Christopher A Zeuthen, M Kartik Das, Shira Mann, Abigail Mauermann, Blair A Parry and 3 more

Abstract read
In one paragraph

Article in JCI insight, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Alyssa K DuBoisInfectious Disease and Microbiome Program, Broad Institute, Cambridge, Massachusetts, USA.
Pierre O AnkomahInfectious Disease and Microbiome Program, Broad Institute, Cambridge, Massachusetts, USA.
Alexis C CampbellDepartment of Emergency Medicine, Massachusetts General Hospital, Boston, Massachusetts, USA.
Renee HuaDepartment of Emergency Medicine, Massachusetts General Hospital, Boston, Massachusetts, USA.
Olivia K NelsonDepartment of Emergency Medicine, Massachusetts General Hospital, Boston, Massachusetts, USA.
Christopher A ZeuthenDepartment of Emergency Medicine, Massachusetts General Hospital, Boston, Massachusetts, USA.
M Kartik DasDepartment of Emergency Medicine, Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA.
Shira MannDepartment of Emergency Medicine, Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA.
Abigail MauermannDepartment of Emergency Medicine, Massachusetts General Hospital, Boston, Massachusetts, USA.
Blair A ParryDepartment of Emergency Medicine, Massachusetts General Hospital, Boston, Massachusetts, USA.
Nathan I ShapiroDepartment of Emergency Medicine, Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA.
Michael R FilbinInfectious Disease and Microbiome Program, Broad Institute, Cambridge, Massachusetts, USA.
Roby P BhattacharyyaInfectious Disease and Microbiome Program, Broad Institute, Cambridge, Massachusetts, USA.

Funding

Single-cell genomic profiling to identify immune signatures of bacterial sepsis in humansR01AI153142 · NIAID · MASSACHUSETTS GENERAL HOSPITAL · PI FILBIN, MICHAEL, GOLDBERG, MARCIA B · 2021 to 2025
$5.0M
Optimizing methods of clinical sample processing for scRNA-seq and mechanistic studies in sepsis to enable reliable, reproducible, and high-yield multi-center collection effortsR21GM148826 · NIGMS · MASSACHUSETTS GENERAL HOSPITAL · PI BHATTACHARYYA, ROBY PAUL, FILBIN, MICHAEL · 2023 to 2024
$418k
NIAID NIH HHS R01 AI153142NIGMS NIH HHS R21 GM148826
6 · The paper itself

Abstract

Single-cell RNA sequencing (scRNA-seq) of peripheral blood mononuclear cells (PBMCs) has enhanced our understanding of host immune mechanisms in small cohorts, particularly in diseases with complex and heterogeneous immune responses such as sepsis. However, standard PBMC isolation from blood requires technical expertise and over 2 hours of on-site processing using Ficoll density gradient separation ("Ficoll") for scRNA-seq compatibility, precluding large-scale sample collection at most clinical sites. To minimize on-site processing, we developed cryopreservation with PBMC recovery offsite (Cryo-PRO), a method of immediate on-site whole-blood cryopreservation and subsequent batched PBMC isolation in a central laboratory prior to sequencing. We compared multimodal single-cell immune profiling results from samples processed using Cryo-PRO versus standard on-site Ficoll separation in 23 patients with sepsis. Key outputs, including cell substate fractions, marker genes, and surface protein expression were similar for each method across multiple cell types and substates, including an important monocyte substate enriched in patients with sepsis. Capture of T cell receptor transcripts was also comparable across both methods. Cryo-PRO reduced on-site sample processing time from more than 2 hours to less than 15 minutes and was reproducible across 2 enrollment sites, thus demonstrating potential for expanding multimodal single-cell analyses in multicenter studies of sepsis and other diseases.

Indexed as

Blood Specimen CollectionCryopreservationLeukocytes, MononuclearSepsisSingle-Cell AnalysisFemaleFicollHumansMaleSingle-Cell Gene Expression AnalysisSpecimen HandlingFicollCellular immune responseClinical ResearchImmunologyInfectious diseaseInnate immunityTranscriptomics

Identifiers

PMID42446933
PMCPMC13502171

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.